![]() CYP4A11/CYP4F2-IN-2 structure
|
Common Name | CYP4A11/CYP4F2-IN-2 | ||
---|---|---|---|---|
CAS Number | 2280834-99-1 | Molecular Weight | 361.44 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C19H27N3O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CYP4A11/CYP4F2-IN-2CYP4A11/CYP4F2-IN-2 (compound 15) is an orally available inhibitor of CYP4A11/4F2 with IC50s of 120 nM and 220 nM, respectively. CYP4A11/CYP4F2-IN-2 inhibits 20-HETE production in rat kidney and has potential inhibitory effects on diabetic nephropathy and autosomal dominant polycystic kidney disease[1]. |
Name | CYP4A11/CYP4F2-IN-2 |
---|
Description | CYP4A11/CYP4F2-IN-2 (compound 15) is an orally available inhibitor of CYP4A11/4F2 with IC50s of 120 nM and 220 nM, respectively. CYP4A11/CYP4F2-IN-2 inhibits 20-HETE production in rat kidney and has potential inhibitory effects on diabetic nephropathy and autosomal dominant polycystic kidney disease[1]. |
---|---|
Related Catalog | |
Target |
CYP4A11, CYP4F2[1] |
References |
Molecular Formula | C19H27N3O4 |
---|---|
Molecular Weight | 361.44 |